Updated daily
# | PubMedId | Deleted | Publication |
---|---|---|---|
36455606 | 0 | Galanaud JP, Genty-Vermorel C, Barrellier MT, et al. 25 mm Hg versus 35 mm Hg elastic compression stockings to prevent post-thrombotic syndrome after deep vein thrombosis (CELEST): a randomised, double-blind, non-inferiority trial. Lancet Haematol. 2022 Dec;9(12):e886-e896. doi: 10.1016/S2352-3026(22)00247-2. | |
36055334 | 0 | Gwozdz AM, de Jong CMM, Fialho LS, et al. Development of an international standard set of outcome measures for patients with venous thromboembolism: an International Consortium for Health Outcomes Measurement consensus recommendation. Lancet Haematol. 2022 Sep;9(9):e698-e706. doi: 10.1016/S2352-3026(22)00215-0. | |
35830171 | 0 | Bikdeli B, Caraballo C, Trujillo-Santos J, et al. Clinical Presentation and Short- and Long-term Outcomes in Patients With Isolated Distal Deep Vein Thrombosis vs Proximal Deep Vein Thrombosis in the RIETE Registry. JAMA Cardiol. 2022 Jul 13. pii: 2793876. doi: 10.1001/jamacardio.2022.1988. | |
34852380 | 0 | Makedonov I, Kahn SR, Abdulrehman J, et al. Prevention of the post thrombotic syndrome with anticoagulation: a narrative review. Thromb Haemost. 2021 Dec 1. doi: 10.1055/a-1711-1263. | |
34518263 | 0 | Galanaud JP, Abdulrehman J, Lazo-Langner A, et al. MUFFIN-PTS trial, Micronized Purified Flavonoid Fraction for the Treatment of Post-Thrombotic Syndrome: protocol of a randomised controlled trial. BMJ Open. 2021 Sep 13;11(9):e049557. doi: 10.1136/bmjopen-2021-049557. | |
34267078 | 0 | Makedonov I, Galanaud JP, Kahn SR. Significance and management of isolated distal deep vein thrombosis. Curr Opin Hematol. 2021 Sep 1;28(5):331-338. doi: 10.1097/MOH.0000000000000670. | |
34027293 | 0 | Li KX, Diendere G, Galanaud JP, et al. Micronized purified flavonoid fraction for the treatment of chronic venous insufficiency, with a focus on postthrombotic syndrome: A narrative review. Res Pract Thromb Haemost. 2021 May 8;5(4):e12527. doi: 10.1002/rth2.12527. eCollection 2021 May. | |
33872825 | 0 | Carlin S, Bond A, Gross P, et al. Initiation of anticoagulation in atrial fibrillation by primary care physicians: Results of a telephone survey. Thromb Res. 2021 Jun;202:176-181. doi: 10.1016/j.thromres.2021.04.004. Epub 2021 Apr 15. | |
33313464 | 0 | Galanaud JP, Genty-Vermorel C, Rolland C, et al. Compression stockings to prevent postthrombotic syndrome: Literature overview and presentation of the CELEST trial. Res Pract Thromb Haemost. 2020 Oct 30;4(8):1239-1250. doi: 10.1002/rth2.12445. eCollection 2020 Nov. | |
33247808 | 0 | Galanaud JP, Trujillo-Santos J, Bikdeli B, et al. Management of isolated distal deep-vein thrombosis with direct oral anticoagulants in the RIETE registry. J Thromb Thrombolysis. 2021 Aug;52(2):532-541. doi: 10.1007/s11239-020-02347-6. Epub 2020 Nov 28. | |
33134787 | 0 | Galanaud JP, Sevestre MA, Pernod G, et al. Epidemiology and 3-year outcomes of combined oral contraceptive-associated distal deep vein thrombosis. Res Pract Thromb Haemost. 2020 Sep 15;4(7):1216-1223. doi: 10.1002/rth2.12409. eCollection 2020 Oct. | |
32898930 | 0 | Galanaud JP, Ducruet T, Kahn SR. Accuracy of contralateral Villalta score to assess for pre-existing chronic venous insufficiency in patients with unilateral deep vein thrombosis. J Thromb Haemost. 2020 Dec;18(12):3309-3315. doi: 10.1111/jth.15091. Epub 2020 Oct 15. | |
32237599 | 0 | Le Collen L, Quere I, Galanaud JP. [Deep-vein thrombosis and pulmonary embolism]. Rev Prat. 2019 Dec;69(10):e327-e336. | |
32230912 | 0 | Makedonov I, Kahn SR, Galanaud JP. Prevention and Management of the Post-Thrombotic Syndrome. J Clin Med. 2020 Mar 27;9(4). pii: jcm9040923. doi: 10.3390/jcm9040923. | |
32110758 | 0 | Dawson AJ, Akaberi A, Galanaud JP, et al. Patient-reported reasons for and predictors of noncompliance with compression stockings in a randomized trial of stockings to prevent postthrombotic syndrome. Res Pract Thromb Haemost. 2019 Dec 29;4(2):269-277. doi: 10.1002/rth2.12296. eCollection 2020 Feb. | |
32028109 | 0 | Calais C, Mercier G, Meusy A, et al. Pulmonary embolism home treatment: What GP want? Thromb Res. 2020 Mar;187:180-185. doi: 10.1016/j.thromres.2020.01.015. Epub 2020 Jan 16. | |
31899848 | 0 | Galanaud JP, Righini M, Le Collen L, et al. Long-term risk of postthrombotic syndrome after symptomatic distal deep vein thrombosis: The CACTUS-PTS study. J Thromb Haemost. 2020 Apr;18(4):857-864. doi: 10.1111/jth.14728. Epub 2020 Feb 11. | |
30656824 | 0 | Righini M, Robert-Ebadi H, Glauser F, et al. Effect of anticoagulant treatment on pain in distal deep vein thrombosis: an ancillary analysis from the cactus trial. J Thromb Haemost. 2019 Mar;17(3):507-510. doi: 10.1111/jth.14387. Epub 2019 Feb 3. | |
29789147 | 0 | Galanaud JP, Blaise S, Sevestre MA, et al. Long-term outcomes of isolated superficial vein thrombosis in patients with active cancer. Thromb Res. 2018 Nov;171:179-186. doi: 10.1016/j.thromres.2018.04.013. Epub 2018 Apr 20. | |
29378357 | 0 | Galanaud JP, Bertoletti L, Amitrano M, et al. Predictors of Post-Thrombotic Ulcer after Acute DVT: The RIETE Registry. Thromb Haemost. 2018 Feb;118(2):320-328. doi: 10.1160/TH17-08-0598. Epub 2018 Jan 29. | |
28942356 | 0 | Ikesaka RT, Kahn SR, Galanaud JP, et al. The importance of post thrombotic syndrome as an outcome after deep venous thrombosis: A survey of Canadian thrombosis clinicians. Thromb Res. 2017 Nov;159:13-15. doi: 10.1016/j.thromres.2017.09.015. Epub 2017 Sep 15. | |
28844444 | 0 | Galanaud JP, Monreal M, Kahn SR. Epidemiology of the post-thrombotic syndrome. Thromb Res. 2018 Apr;164:100-109. doi: 10.1016/j.thromres.2017.07.026. Epub 2017 Jul 24. | |
28363340 | 0 | Righini M, Galanaud JP, Le Gal G. Anticoagulant therapy for symptomatic calf deep vein thrombosis - Authors' reply. Lancet Haematol. 2017 Apr;4(4):e156. doi: 10.1016/S2352-3026(17)30023-6. | |
28204995 | 0 | Dranitsaris G, Shane LG, Galanaud JP, et al. Dalteparin or vitamin K antagonists to prevent recurrent venous thromboembolism in cancer patients: a patient-level economic analysis for France and Austria. Support Care Cancer. 2017 Jul;25(7):2093-2102. doi: 10.1007/s00520-017-3610-2. Epub 2017 Feb 15. | |
27836513 | 0 | Righini M, Galanaud JP, Guenneguez H, et al. Anticoagulant therapy for symptomatic calf deep vein thrombosis (CACTUS): a randomised, double-blind, placebo-controlled trial. Lancet Haematol. 2016 Dec;3(12):e556-e562. doi: 10.1016/S2352-3026(16)30131-4. Epub 2016 Nov 8. | |
27639012 | 0 | Galanaud JP, Monreal M, Kahn SR. Predictors of the post-thrombotic syndrome and their effect on the therapeutic management of deep vein thrombosis. J Vasc Surg Venous Lymphat Disord. 2016 Oct;4(4):531-4. doi: 10.1016/j.jvsv.2015.08.005. Epub 2016 Jan 7. | |
26780743 | 0 | Kahn SR, Galanaud JP, Vedantham S, et al. Guidance for the prevention and treatment of the post-thrombotic syndrome. J Thromb Thrombolysis. 2016 Jan;41(1):144-53. doi: 10.1007/s11239-015-1312-5. | |
26188923 | 0 | Almosni J, Meusy A, Frances P, et al. Practice variation in the management of distal deep vein thrombosis in primary vs. secondary cares: A clinical practice survey. Thromb Res. 2015 Sep;136(3):526-30. doi: 10.1016/j.thromres.2015.06.013. Epub 2015 Jun 12. |